Cancer Skin Cancer Treatment Treating Actinic Keratosis With Solaraze (Diclofenac) Topical Cream By Timothy DiChiara, PhD Timothy DiChiara, PhD Timothy J. DiChiara, PhD, is a former research scientist and published writer specializing in oncology. Learn about our editorial process Updated on April 19, 2020 Medically reviewed by Leah Ansell, MD Medically reviewed by Leah Ansell, MD LinkedIn Leah Ansell, MD, is board-certified in cosmetic and medical dermatology. She is an assistant professor at Columbia University and works in private practice in New York City. Learn about our Medical Expert Board Print Table of Contents View All Table of Contents How It Works How to Use Side Effects Solaraze gel is a skin-use only (topical) prescription medicine used to treat actinic keratosis, a common precancerous skin condition caused by prolonged and repeated sun exposure. The gel can be used on all areas of the body. Solaraze is just one type of treatment for the dry, scaly lesions of actinic keratosis (AK). Options include cryosurgery (freezing), curettage (scraping), shave removal, laser therapy, chemical peels, photodynamic therapy, and topical (applied to the skin only) creams such as Aldara (imiquimod), Picato (ingenol mebutate) and Calcitrene (calcipotriene) combined with fluorouracil, and Solaraze (diclofenac, diclofenac 3% gel, diclofenac sodium). alvarez / Getty Images Note: This information may not cover all possible precautions, interactions or adverse effects for this drug. If you have any questions about any drug you are taking, check with your healthcare professional. How It Works Although the exact way it works is not completely understood, it is classified as a nonsteroidal anti-inflammatory drug (NSAID), just like aspirin and ibuprofen. NSAIDs inhibit a molecule in the body called cyclo-oxygenase-2 (COX-2), which in turn reduces the synthesis of a hormone-like substance called prostaglandin. Sun damage and AK have been linked with raised prostaglandins in the skin. Three clinical trials were conducted that led to the approval of diclofenac gel by the Food and Drug Administration (FDA). A total of 427 patients with five or more AK lesions on their scalp, forehead, face, forearm or hand were treated with either diclofenac or a dummy (placebo) gel for three months. Thirty days after the end of treatment, 30% to 50% of the AK lesions were completely cleared, double or triple the number seen in the dummy gel group. The best results were seen with AKs on the face. Another study tested the effect of diclofenac on AKs that had already been treated with cryosurgery (freezing). The results were even better: 46% of the patients saw all of their AK lesions completely cleared, compared with only 21% of the patients who didn't receive diclofenac after cryosurgery. Solaraze is not for everyone. Tell your healthcare provider about all of your medical conditions before starting to use diclofenac gel, including if you: Have an active ulcerHave liver problemsHave kidney problemsHave had a previous bad reaction to aspirin, ibuprofen or other NSAIDs How to Use Diclofenac Solaraze gel should be gently rubbed on your lesions twice a day. The amount needed depends upon the size of the lesion, but be sure that enough is applied to adequately cover each lesion. Your healthcare provider may recommend that you treat a general area with Solaraze, rather than just specific lesions, which may help clear lesions that are not yet visible. Your practitioner will likely recommend you use Solaraze for 60 to 90 days. However, your lesions may not heal completely until 30 days after you stopped using it. If you see that some lesions are not responding to the gel, see your healthcare provider. Side Effects and Warnings In clinical trials, the most common reactions reported involved the skin and were generally mild to moderate in severity. These included: Itchy rashDry skinSkin peelingRedness Most of these reactions went away when the therapy was discontinued. It is important to avoid the sun and tanning booths while you are using diclofenac gel since it causes an increased sensitivity to sunburns. It should not be applied to open skin wounds, infections or other skin problems, or come in contact with your eyes. Children should not take diclofenac, and do not use this product if you are pregnant or nursing. Klisyri (Tirbanibulin) - Topical 6 Sources Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy. Dodds A, Chia A, Shumack S. Actinic keratosis: rationale and management. Dermatol Ther (Heidelb). 2014;4(1):11–31. doi:10.1007/s13555-014-0049-y Nelson C, Rigel D, Smith S, Swanson N, Wolf J. Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze). J Drugs Dermatol. 2004;3(4):401-7. Kunstfeld R. Solaraze. Melanoma Research. 2010;20. doi:10.1097/01.cmr.0000382772.75569.3a Ibrahim SF, Brown MD. Actinic keratoses: a comprehensive update. J Clin Aesthet Dermatol. 2009;2(7):43–48. Berlin JM, Rigel DS. Diclofenac sodium 3% gel in the treatment of actinic keratoses postcryosurgery. J Drugs Dermatol. 2008 7(7):669-73. Nelson CG, Spencer J, Nelson CG Jr. A single-arm, open-label efficacy and tolerability study of diclofenac sodium 3% gel for the treatment of actinic keratosis of the upper and lower lip. J Drugs Dermatol. 2007 6(7):712-717. Additional Reading "Solaraze Gel Prescribing Information." PharmaDerm. Newman MD, Weinberg JM. Topical therapy in the treatment of actinic keratosis and basal cell carcinoma. Cutis. 2007 79(4 Suppl):18-28. By Timothy DiChiara, PhD Timothy J. DiChiara, PhD, is a former research scientist and published writer specializing in oncology. See Our Editorial Process Meet Our Medical Expert Board Share Feedback Was this page helpful? Thanks for your feedback! What is your feedback? Other Helpful Report an Error Submit